JVMAX
Price
$28.79
Change
+$0.02 (+0.07%)
Updated
Jul 13 closing price
Net Assets
23.28B
TASMX
Price
$31.45
Change
+$0.12 (+0.38%)
Updated
Jul 13 closing price
Net Assets
640.22M
Interact to see
Advertisement

JVMAX vs TASMX

JVMAX vs TASMX Comparison Chart in %
View a ticker or compare two or three
VS
JVMAX vs. TASMX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMAX is a Hold and TASMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMAX has more cash in the bank: 23.3B vs. TASMX (640M). TASMX pays higher dividends than JVMAX: TASMX (1.18) vs JVMAX (0.50). JVMAX was incepted earlier than TASMX: JVMAX (29 years) vs TASMX (11 years). JVMAX (1.11) is less costly to investors than TASMX (0.81). JVMAX (48.00) and TASMX (48.00) have comparable annual turnover. TASMX has a lower initial minimum investment than JVMAX: TASMX (0) vs JVMAX (1000). TASMX annual gain was more profitable for investors over the last year : 10.83 vs. JVMAX (5.41). JVMAX return over 5 years is better than : 10.76 vs. TASMX (-1.24).
JVMAXTASMXJVMAX / TASMX
Total Expense Ratio1.100.81136%
Annual Report Gross Expense Ratio1.110.81137%
Fund Existence29 years11 years-
Gain YTD11.64113.14689%
Front Load5%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.3B640M3,641%
Annual Yield % from dividends0.501.1842%
Returns for 1 year5.4110.8350%
Returns for 3 years15.4714.44107%
Returns for 5 years10.76-1.24-870%
Returns for 10 years51.6827.45188%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ANVIX30.72N/A
N/A
Virtus NFJ Large-Cap Value Fund Inst
BDHAX9.08N/A
N/A
BlackRock Dynamic High Income Inv A
PAGHX143.05N/A
N/A
Permanent Portfolio Aggressive Growth C
RSMVX13.52N/A
N/A
William Blair Small-Mid Cap Value R6
JFNCX73.02-0.57
-0.77%
Janus Henderson Global Life Sciences C